Sunkaraneni S - Search Results

1

An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous Determination of Ciclesonide and Active Metabolite Desisobutyryl-Ciclesonide in Human Serum and Its Application to a Clinical Study.

Chen YL, Wang W, Gatien Ngounou Wetie A, Shi L, Eddy J, John Lin ZP, Sunkaraneni S. Chen YL, et al. Among authors: sunkaraneni s. J Appl Lab Med. 2020 Jan 1;5(1):41-53. doi: 10.1373/jalm.2019.029397. J Appl Lab Med. 2020. PMID: 31662413 Free article.

2

Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.

Sunkaraneni S, Ludwig EA, Passarell JA, Blum D, Grinnell T, Fiedler-Kelly J. Sunkaraneni S, et al. J Clin Pharmacol. 2018 Jul;58(7):927-938. doi: 10.1002/jcph.1086. Epub 2018 Mar 12. J Clin Pharmacol. 2018. PMID: 29528499 Clinical Trial.

3

Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.

Hopkins SC, Sunkaraneni S, Skende E, Hing J, Passarell JA, Loebel A, Koblan KS. Hopkins SC, et al. Among authors: sunkaraneni s. Clin Drug Investig. 2016 Feb;36(2):137-46. doi: 10.1007/s40261-015-0358-7. Clin Drug Investig. 2016. PMID: 26597180 Free PMC article.

4

Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate.

Gidal BE, Jacobson MP, Ben-Menachem E, Carreño M, Blum D, Soares-da-Silva P, Falcão A, Rocha F, Moreira J, Grinnell T, Ludwig E, Fiedler-Kelly J, Passarell J, Sunkaraneni S. Gidal BE, et al. Among authors: sunkaraneni s. Acta Neurol Scand. 2018 Sep;138(3):203-211. doi: 10.1111/ane.12950. Epub 2018 May 6. Acta Neurol Scand. 2018. PMID: 29732549 Free PMC article. Clinical Trial.

5

Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters.

Gidal BE, Mintzer S, Schwab M, Schutz R, Kharidia J, Blum D, Grinnell T, Sunkaraneni S. Gidal BE, et al. Among authors: sunkaraneni s. Epilepsy Res. 2017 Sep;135:64-70. doi: 10.1016/j.eplepsyres.2017.05.005. Epub 2017 May 18. Epilepsy Res. 2017. PMID: 28624574 Clinical Trial.

6

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy.

Sunkaraneni S, Passarell JA, Ludwig EA, Fiedler-Kelly J, Pitner JK, Grinnell TA, Blum D. Sunkaraneni S, et al. Clin Pharmacol. 2017 Jun 27;9:65-72. doi: 10.2147/CPAA.S133815. eCollection 2017. Clin Pharmacol. 2017. PMID: 28721105 Free PMC article.

7

Population Pharmacokinetic Evaluation and Missed-Dose Simulations for Eslicarbazepine Acetate Monotherapy in Patients With Partial-Onset Seizures.

Sunkaraneni S, Blum D, Ludwig E, Chudasama V, Fiedler-Kelly J, Marvanova M, Bainbridge J, Phillips L. Sunkaraneni S, et al. Clin Pharmacol Drug Dev. 2018 Mar;7(3):287-297. doi: 10.1002/cpdd.382. Epub 2017 Sep 7. Clin Pharmacol Drug Dev. 2018. PMID: 28881418

8

Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic Use.

Nayak S, Sander O, Al-Huniti N, de Alwis D, Chain A, Chenel M, Sunkaraneni S, Agrawal S, Gupta N, Visser SAG. Nayak S, et al. Among authors: sunkaraneni s. Clin Pharmacol Ther. 2018 Mar;103(3):378-383. doi: 10.1002/cpt.978. Epub 2018 Jan 13. Clin Pharmacol Ther. 2018. PMID: 29330855 Free PMC article.

9

Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures.

Sunkaraneni S, Ludwig E, Fiedler-Kelly J, Hopkins S, Galluppi G, Blum D. Sunkaraneni S, et al. J Pharmacokinet Pharmacodyn. 2018 Aug;45(4):649-658. doi: 10.1007/s10928-018-9596-7. Epub 2018 Jun 9. J Pharmacokinet Pharmacodyn. 2018. PMID: 29948795 Free PMC article.

10

A Pharmacokinetic Study Comparing Eslicarbazepine Acetate Administered Orally as a Crushed or Intact Tablet in Healthy Volunteers.

Sunkaraneni S, Kharidia J, Schutz R, Blum D, Cheng H. Sunkaraneni S, et al. Clin Pharmacol Drug Dev. 2016 Jul;5(4):278-84. doi: 10.1002/cpdd.242. Epub 2016 Feb 8. Clin Pharmacol Drug Dev. 2016. PMID: 27249205 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page